In our study, five of these genes (AKR1C1, ALOX12, CARS1, CRYAB, and PHKG2) were associated with a poor prognosis in CRC, while the remaining three (ATP5MC3, HMGCR, and FDFT1) were associated with a better prognosis. This evidence concerns the gene PHKG2 and colorectal carcinoma.